[1]刘玉川,崔彦魁,程鹏.脑脊液外泌体lncRNA SOCS2-AS1预测脑胶质瘤复发的价值[J].中国临床神经外科杂志,2022,27(09):751-753757.[doi:10.13798/j.issn.1009-153X.2022.09.010]
　LIU Yu-chuan,CUI Yan-kui,CHENG Peng.Predictive value of cerebrospinal fluid exosomal lncRNA SOCS2-AS1 in postoperative recurrence of human brain glioma[J].,2022,27(09):751-753757.[doi:10.13798/j.issn.1009-153X.2022.09.010]
点击复制

脑脊液外泌体lncRNA SOCS2-AS1预测脑胶质瘤复发的价值()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年09期
页码:
751-753757
栏目:
论著
出版日期:
2022-09-30

文章信息/Info

Title:
Predictive value of cerebrospinal fluid exosomal lncRNA SOCS2-AS1 in postoperative recurrence of human brain glioma
文章编号:
1009-153X（2022）09-0751-03
作者:
刘玉川; 崔彦魁; 程鹏
454000 河南，焦作市第二人民医院（河南理工大学第一附属医院）神经外科（刘玉川、崔彦魁、程鹏）
Author(s):
LIU Yu-chuan;  CUI Yan-kui;  CHENG Peng
Department of Neurosurgery, Jiaozuo Second People's Hospital (The First Affiliated Hospital of Henan University of Technology), Jiaozuo 454000, China
关键词:
脑胶质瘤; 脑脊液; lncRNA SOCS2-AS1; 肿瘤复发
Keywords:
Glioma;  Cerebrospinal fluid;  Long noncoding RNA SOCS2-AS1;  Postoperative recurrence
分类号:
R739.41;Q786
DOI:
10.13798/j.issn.1009-153X.2022.09.010
文献标志码:
A
摘要:
目的 探讨脑脊液lncRNA SOCS2-AS1预测脑胶质瘤术后复发的价值。方法 选取2017年1月至2018年1月手术治疗的脑胶质瘤84例（高级别胶质瘤46例，低级别胶质瘤38例），另选取将康体检者30例为对照，腰椎穿刺术取脑脊液并分离外泌体，用RT-PCR检测外泌体lncRNA SOCS2-AS1水平。以lncRNA SOCS2-AS1相对表达量中位数为截断值，将胶质瘤分为高表达组和低表达组。结果 胶质瘤脑脊液外泌体lncRNA SOCS2-AS1相对表达量明显高于对照组（P<0.05），而且高级别胶质瘤脑脊液lncRNA SOCS2-AS1相对表达量明显高于低级别胶质瘤（P<0.05）。多因素logistic回归分析显示，脑脊液外泌体lncRNA SOCS2-AS1高表达是脑胶质瘤术后复发的独立影响因素（P<0.05）。ROC曲线分析显示，脑脊液外泌体lncRNA SOCS2-AS1高表达预测脑胶质瘤术后复发的曲线下面积为0.917，灵敏度为85.78%，特异度为93.10%。结论 脑胶质瘤病人脑脊液外泌体lncRNA SOCS2-AS1表达水平升高；脑脊液外泌体lncRNA SOCS2-AS1高表达对脑胶质瘤术后复发有较高的的预测价值。
Abstract:
Objective To investigate the predictive value of cerebrospinal fluid (CSF) exosomal lncRNA SOCS2-AS1 in predicting postoperative recurrence of human brain glioma. Methods Eighty-four patients with glioma (46 high-grade glioma and 38 low-grade glioma) who underwent surgery from January 2017 to January 2018 were selected, and 30 health examination subjects were selected as control. CSF was extracted by lumbar puncture and exosomes were isolated. The level of exosomal lncRNA SOCS2-AS1 was detected by RT-PCR. The glioma patients were divided into high expression group and low expression group according to the median expression level of lncRNA SOCS2-AS1. Results The expression level of CSF exosomal lncRNA SOCS2-AS1 of glioma was significantly higher than that of control group (P<0.05), and the expression level of CSF exosomal lncRNA SOCS2-AS1 of high-grade glioma was significantly higher than that of low-grade glioma (P<0.05). Multivariate logistic regression analysis showed that high expression of CSF exosomal lncRNA SOCS2-AS1 was an independent risk factor for postoperative recurrence of glioma (P<0.05). ROC curve analysis showed that the area under the curve of high expression of CSF exosomal lncRNA SOCS2-AS1 for predicting postoperative recurrence of glioma was 0.917, with a sensitivity of 85.78% and a specificity of 93.10%. Conclusions The expression level of CSF exosomal lncRNA SOCS2-AS1 is up-regulated in patients with glioma. The high expression of CSF exosomal lncRNA SOCS2-AS1 has a high predictive value for postoperative recurrence of glioma.

参考文献/References:

[1] 何远秀，钟文君，李　悦. 复发脑胶质瘤的诊断及治疗进展[J]. 海南医学，2021，32（2）：246-249.
[2] Isaac R, Reis FCG, Ying W, et al. Exosomes as mediators of intercellular crosstalk in metabolism [J]. Cell Metab, 2021, 33(9): 1744-1762.
[3] 崔舒悦，汤　帅，丁晓玲，等. 间充质干细胞及其外泌体对肿瘤影响的研究进展[J]. 中国肺癌杂志，2022，25（5）：351-357.
[4] Li Z, Meng X, Wu P, et al. Glioblastoma cell-derived lncRNA-containing exosomes induce microglia to produce complement C5, promoting chemotherapy resistance [J]. Cancer Immunol Res, 2021, 9(12): 1383-1399.
[5] Misawa A, Takayama K, Urano T, et al. Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells [J]. J Biol Chem, 2016, 291(34): 17861-17880.
[6] Qu Y, Qi L, Hao L, et al. Upregulation of circ-ASPH contri-butes to glioma cell proliferation and aggressiveness by targeting the miR-599/AR/SOCS2-AS1 signaling pathway [J]. Oncol Lett, 2021, 21(5): 388.
[7] Zheng Z, Li X, You H, et al. LncRNA SOCS2-AS1 inhibits progression and metastasis of colorectal cancer through stabilizing SOCS2 and sponging miR-1264 [J]. Aging (Albany NY), 2020, 12(11): 10517-10526.
[8] 杨　智，唐　栋，曹　磊，等. 血清外泌体miRNA-30a-5p在人脑胶质瘤诊断及预后评价中的作用[J]. 中国临床神经外科杂志，2020，25（5）：296-298.
[9] 田　艳，魏可欣，张向宁. 脑脊液外泌体miR-146a与人脑胶质瘤术后复发的相关性[J]. 中国临床神经外科杂志，2021，26（4）：250-253.
[10] 李皓然，王海洋，董　军. 细胞外囊泡在脑胶质瘤中的研究进展及其应用前景[J]. 中华神经外科杂志，2022，38（4）：429-432.
[11] 史竞彤，陈敏捷. 恶性肿瘤来源外泌体在巨噬细胞M2极化中作用的研究进展[J]. 实用肿瘤学杂志，2022，36（1）：59-63.
[12] Zhao W, Xie Q. Exosomal lncRNA-mediated intercellular communication promotes glioblastoma chemoresistance [J]. Cancer Immunol Res, 2021, 9(12): 1372.
[13] Movahedpour A, Khatami SH, Khorsand M, et al. Exosomal noncoding RNAs: key players in glioblastoma drug resistance [J]. Mol Cell Biochem, 2021, 476(11): 4081-4092.
[14] Wu D, Sun J, Wang H, et al. LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression [J]. Neurosci Lett, 2021, 765: 136248.
[15] 程慧冉. 多模态导航辅助电生理技术应用于脑胶质瘤治疗的效果及术后复发的影响因素分析[J]. 实用癌症杂志，2022，37（5）：836-839.
[16] 连露露，范小璇，赵晓平，等. 复发性脑胶质瘤的临床治疗进展[J]. 国际神经病学神经外科学杂志，2022，49（2）：84-88.

相似文献/References:

[1]付　锴　江普查　宫　睿　王　伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
　FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(09):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳　琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]曾家良　谢　飞　叶永强　陈志远　郝坚强　刘　欢.腰大池引流术对外伤性蛛网膜下腔出血患者脑脊液NO、ET-1水平的影响[J].中国临床神经外科杂志,2017,(03):162.[doi:10.13798/j.issn.1009-153X.2017.03.012]
　ZENG Jia-liang,XIE Fei,YE Yong-qiang,et al.Effect of lumbar cistern drainage on CSF levels of NO and ET-1 in patients with traumatic subarachnoid hemorrhage[J].,2017,(09):162.[doi:10.13798/j.issn.1009-153X.2017.03.012]
[4]武元星　郝京京　王　强.血清及脑脊液降钙素原在神经外科术后颅内感染早期诊断中的应用[J].中国临床神经外科杂志,2017,(04):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
　WU Yuan-xing,HAO Jing-jing,WANG Qiang..Value of procalcitonin in serum and cerebrospinal fluid to diagnosis of intracranial infection early after craniotomy[J].,2017,(09):237.[doi:10.13798/j.issn.1009-153X.2017.04.010]
[5]肖高华　陈　钢　陈　峥　刘　科　刘　笑　熊绍棠.急性颅脑损伤外周血垂体前叶激素及脑脊液硫化氢水平变化[J].中国临床神经外科杂志,2017,(05):310.[doi:10.13798/j.issn.1009-153X.2017.05.009]
　XIAO Gao-hua,CHEN Zheng,CHEN Gang,et al.Changes of plasma anterior pituitary hormone and CSF H2S in patients with acute craniocerebral trauma[J].,2017,(09):310.[doi:10.13798/j.issn.1009-153X.2017.05.009]
[6]闫　珊　徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
　YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(09):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[7]呼铁民　褚会松　田　甜　王昆鹏　杨国军　杨立军　王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
　HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(09):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[8]汪超甲 综述　王　辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[9]高剑峰　姚庆和　李晓辉　龙宇波　陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
　GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(09):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[10]刘　靖　吴立权　黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
　LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(09):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[11]罗似亮　夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
　LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(09):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[12]田　艳　魏可欣　张向宁.脑脊液外泌体miR-146a与人脑胶质瘤术后复发的相关性[J].中国临床神经外科杂志,2021,26(04):250.[doi:10.13798/j.issn.1009-153X.2021.04.009]
　TIAN Yan,WEI Ke-xin,ZHANG Xiang-ning. ..Correlation between cerebrospinal fluid level of exosomal miR-146a and postoperative recurrence of glioma[J].,2021,26(09):250.[doi:10.13798/j.issn.1009-153X.2021.04.009]

备注/Memo

备注/Memo:
（2022-06-25收稿，2022-08-15修回）
更新日期/Last Update: 2022-10-31